Effective July 1, 2025, there will be changes to how authorization requests are submitted through the UnitedHealthcare Provider Portal for oncology Part B drugs under the Optum Cancer Guidance Program and specialty (non-oncology) Part B drugs.
The changes consolidate authorization pathways through MBMNow. Additionally, the visual experience for non-oncology submissions will be different and certain non-oncology drugs may be eligible for auto-approval.
For more information, review the Specialty Drugs and Oncology Drugs Authorization Process Changes Reference Sheet.
The process change doesn’t impact existing approved authorizations for Part B drugs; those remain in effect until the end date on the authorization. You won’t need to submit a new request until the authorization expires or you change the therapy.
Other Resources on the UnitedHealthcare Provider Portal
Find oncology Part B drugs that require prior authorization on the oral and injectable chemotherapy and related cancer therapies page.
Find specialty Part B drugs requiring prior authorization in the Medicare Part B Step Therapy Programs policy and in the Medicare Advantage Prior Authorization List (under Medicare Advantage, choose the link listing “Peoples Health”).
Contact Provider Services if you need assistance: 1-877-842-3210.
